In this presentation, which was recorded on Dec. 5, 2022 as part of the NF2 Accelerator Meetup initiative at the Children's Tumor Foundation., CTF Chief Scientific Officer Salvatore LaRosa, PhD provided an overview of CTF-funded research in NF2. Topics included CTF’s efforts in gene therapy, future investments in NF2 clinical trials, a second drug in the INTUITT Trial for NF2, and the NF2 projects we have committed to for 2023.
Click here for more about CTF's NF2 Accelerator Initiative.
